Andrew R. Branagan

Also affiliated with Massachusetts General Hospital, Global Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia”.

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

Leukemia(2021)10.1038/s41375-021-01417-9

N/A

1.8DataRank · unranked

83 citations

Kirsten Meid, Joshua Gustine, Carly Leventoff, Timothy P. White, Catherine Flynn +17 more

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

Blood(2021)10.1182/blood.2021012953

N/A

1.4DataRank · unranked

53 citations

Kirsten Meid, Zachary R. Hunter, Catherine Flynn, Shayna Sarosiek, Carly Leventoff +17 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0.416DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Cell‐free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia

American Journal of Hematology(2021)10.1002/ajh.26184

N/A

0DataRank · unranked

12 citations

Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi +14 more

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

Blood Advances(2024)10.1182/bloodadvances.2023012111

N/A

0DataRank · unranked

4 citations

Jorge J. Castillo, Shayna Sarosiek, Andrew R. Branagan, Catherine Flynn, Kirsten Meid +12 more

ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells

British Journal of Haematology(2024)10.1111/bjh.19756

N/A

0DataRank · unranked

3 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Zachary R. Hunter, Maria Luisa Guerrera +15 more

365 Single-cell transcriptional profiles of cilta-cel and ide-cel associate with response in multiple myeloma

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0365

N/A

0DataRank · unranked

0 citations

Charlotte Graham, Aiyana Parker, Maria Dolaher, Kevin Lindell, Deshea L Harris +16 more